Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1973 | 2 |
| 1974 | 4 |
| 1975 | 4 |
| 1976 | 6 |
| 1977 | 2 |
| 1978 | 2 |
| 1979 | 4 |
| 1980 | 2 |
| 1981 | 2 |
| 1982 | 3 |
| 1984 | 6 |
| 1985 | 3 |
| 1986 | 2 |
| 1988 | 2 |
| 1989 | 5 |
| 1990 | 1 |
| 1991 | 1 |
| 1992 | 4 |
| 1993 | 4 |
| 1994 | 3 |
| 1995 | 4 |
| 1996 | 4 |
| 1997 | 6 |
| 1998 | 4 |
| 1999 | 5 |
| 2000 | 6 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2008 | 1 |
| 2024 | 0 |
Search Results
102 results
Results by year
Page 1
Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S162-75. doi: 10.1016/s0039-6257(02)00292-8.
Surv Ophthalmol. 2002.
PMID: 12204714
Review.
Cholinergic vasoconstriction in the eye.
J Ocul Pharmacol. 1990 Fall;6(3):195-202. doi: 10.1089/jop.1990.6.195.
J Ocul Pharmacol. 1990.
PMID: 2290067
Review.
Latanoprost as a new horizon in the medical management of glaucoma.
Curr Opin Ophthalmol. 1996 Apr;7(2):11-7. doi: 10.1097/00055735-199604000-00003.
Curr Opin Ophthalmol. 1996.
PMID: 10163315
Review.
Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment.
Exp Eye Res. 2004 Apr;78(4):759-66. doi: 10.1016/j.exer.2003.11.016.
Exp Eye Res. 2004.
PMID: 15037110
Review.
Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids.
Surv Ophthalmol. 1997 Feb;41 Suppl 2:S47-52. doi: 10.1016/s0039-6257(97)80007-0.
Surv Ophthalmol. 1997.
PMID: 9154276
Review.
[Leukotrienes].
Duodecim. 1984;100(16):971-3.
Duodecim. 1984.
PMID: 6096108
Finnish.
No abstract available.
Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
Prog Retin Eye Res. 2000 Jul;19(4):459-96. doi: 10.1016/s1350-9462(00)00003-3.
Prog Retin Eye Res. 2000.
PMID: 10785618
Review.
From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.
Invest Ophthalmol Vis Sci. 2001 May;42(6):1134-45.
Invest Ophthalmol Vis Sci. 2001.
PMID: 11328719
Review.
No abstract available.
Vasodynamic and angiogenic effects of eicosanoids in the eye.
Prog Clin Biol Res. 1989;312:155-70.
Prog Clin Biol Res. 1989.
PMID: 2678142
Review.
Cite